# Guidance for Industry: Recommendations for the Assessment of Donor Suitability and Blood Product Safety in Cases of Suspected Severe Acute Respiratory Syndrome (SARS) or Exposure to SARS - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/guidance-for-industry-recommendations-for-the-assessment-of-donor-suitability-and-blood-product-safety-in-cases-of-suspected-severe-acute-respiratory-syndrome-sars-or-exposure-to-sars/c0e0abf6-5a1e-422e-a51d-6fce1784f489

> FDA guidance document: Guidance for Industry: Recommendations for the Assessment of Donor Suitability and Blood Product Safety in Cases of Suspected Severe Acute Respiratory Syndrome (SARS) or Exposure to SARS. Issue date: April 17, 2003. Get complete insights and analysis.

---

## Details

- Title: Guidance for Industry: Recommendations for the Assessment of Donor Suitability and Blood Product Safety in Cases of Suspected Severe Acute Respiratory Syndrome (SARS) or Exposure to SARS
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2003-04-17
- Last Changed: 2019-06-15

## Related Documents

- [Determining Donor Eligibility for Autologous Donors of Blood and Blood Components Intended Solely for Autologous Use - Compliance Policy:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/determining-donor-eligibility-for-autologous-donors-of-blood-and-blood-components-intended-solely-for-autologous-use-compliance-policy-guidance-for-industry/66ca6a85-aebe-4b20-a0ba-d0f7e4e393d3)
- [Recommendations for Assessment of Donor Suitability and Blood and Blood Product Safety in Cases of Possible Exposure to Anthrax:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-assessment-of-donor-suitability-and-blood-and-blood-product-safety-in-cases-of-possible-exposure-to-anthrax-guidance-for-industry/3c6a09c1-24ab-442b-b40a-2ab825c7ee4a)
- [Biological Product Deviation Reporting for Blood and Plasma Establishments:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/biological-product-deviation-reporting-for-blood-and-plasma-establishments-guidance-for-industry/6c58653c-8367-4da8-9b28-4e92356ee9c7)